Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Nat Neurosci. 2011 Nov 27;15(2):274–283. doi: 10.1038/nn.2997

Figure 5. Disruption of MeCP2 methyl-DNA binding leads to deregulation of gene expression.

Figure 5

(a) Bdnf, Crh and Sgk mRNA expression in the hypothalamus of Mecp2T158A/y mice compared to Mecp2+/y littermates (n = 4). Bars represent mean ± SEM. * p-value < 0.05; two-tailed t-test with Bonferroni correction. (b) Bdnf, Crh and Sgk mRNA expression in the striatum of Mecp2T158A/y mice and Mecp2+/y littermates (n = 4). Bars represent mean ± SEM. * p-value < 0.05; two-tailed t-test with Bonferroni correction. (c) MeCP2 T158A mutation does not impair the association of MeCP2 with HDAC1 or Sin3a. MeCP2 immunoprecipitation from brain nuclear extracts prepared from Mecp2T158A/y and Mecp2+/y littermates are probed with indicated antibodies.